|
|
|
|
|
|
|
|
|
|
Don't miss the most influential global leaders in biotechnology and pharma discussing innovation, vaccines, gene therapy, precision medicine, and the 2018 global forecast in this year's lineup of Super Sessions at BIO 2018!
Explore the sessions below, and add the ones you want to see to your personalized myBIO agenda. Check back often as additional speakers are confirmed!
Super Sessions are open to Education Access, Convention Access, and Convention Access + Partnering registrants.
| |
| |
|
|
|
|
|
|
What’s next for R&D in the global pharmaceutical industry, highlighting noteworthy differences in disease areas of focus, and therapeutic targets for companies of all sizes.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Sam Ulin, Principal, ClearView Healthcare Partners
Newton, Massachusetts
| |
| |
|
|
|
|
Also Featuring:
- Chris Von Seggern, Partner, ClearView Healthcare Partners
| |
| |
|
|
|
|
Explore the similarities between running a successful biotech company and a football franchise: team building, collaborations, innovation, leadership, culture, and more.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Jonathan Kraft, President, The Kraft Group and the New England Patriots
Foxborough, Massachusetts
| |
| |
|
|
|
|
Also Featuring:
- Bill Sibold, Executive Vice President and Head, Sanofi Genzyme
| |
| |
|
|
|
|
The opportunities and challenges facing vaccine developers and manufacturers and the importance of continued innovation in vaccines.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Michael Nally, President, Merck Vaccines
Philadelphia, Pennsylvania
| |
| |
|
|
|
|
Also Featuring:
- Stanley Erck, President and Chief Executive Officer, NOVAVAX
- Jacqueline Keith [Moderator], President, J Keith Consulting Corp
- David Loew, Head, Global Commercial Operations, Sanofi Pasteur
- Gordon Naylor, President, Sequirus
- Rajeev Venkayya, President, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited
| |
| |
|
|
|
|
Deal makers explore the impact that market forces have on pharmaceutical and biotech companies.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Neel Patel [Moderator], Managing Director, Portfolio & Commercial Strategy, Syneos Health Consulting
San Francisco, California
| |
| |
|
|
|
|
Also Featuring:
- Marianne De Backer, PhD, MBA, Vice President, Venture Investments, Johnson & Johnson Innovation
- Ji Li, Executive Vice President, Global Head of Business Development, BeiGene, Ltd.
- David Thomas, CFA, Managing Director, Industry Research and Policy Analysis, Biotechnology Innovation Organization (BIO)
- Dr. Thomas Zioncheck, Global Head, Genentech Business Development for Neuroscience, Ophthalmology, and Research Tools & Technologies, Genentech, A Member of the Roche Group
| |
| |
|
|
|
|
Improving human health, potential treatments and cures for disease, and new approaches to drug delivery.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Steve Bagshaw [Moderator], Chief Executive Officer, FUJIFILM Diosynth Biotechnologies
Billingham, United Kingdom
| |
| |
|
|
|
|
Also Featuring:
- Sandy Macrae, President and Chief Executive Officer, Sangamo Therapeutics
- John Pieracci, Director, Gene Therapy Process Development, Biogen
- Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer
| |
| |
|
|
|
|
The intersection of biology, computer science, statistics, and engineering and the future of precision medicine.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Dr. Thomas J. Lynch, Jr. [Moderator], Executive Vice President, Chief Scientific Officer, Bristol-Myers Squibb
Princeton Pike, New Jersey
| |
| |
|
|
|
|
Also Featuring:
- Melanie Nallicheri, Chief Business Officer and Head of Biopharma, Foundation Medicine
- Scott D. Solomon, The Edward D. Frohlich Distinguished Chair Professor of Medicine, Harvard Medical School
| |
| |
|
|
|
|
How are advances in hardware, software, and mobile technologies reconstructing the delivery of healthcare?
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Rachel Sha [Moderator], Vice President, Digital Business Development & Licensing, Sanofi
Boston, Massachusetts
| |
| |
|
|
|
|
Also Featuring:
- Marta Bralic, Vice President, Business Development, FlatIron Health
- Dr. Luba Greenwood, Strategic Business Development, Corporate Ventures at Verily, an Alphabet Company
- Dr. Iya Khalil, Chief Commercial Officer, EVP and Co-founder, GNS Healthcare
| |
| |
|
|
|
|
The latest commercial, scientific and ethical issues facing innovation stakeholders today, and what to expect in the year ahead.
| |
| |
|
|
|
|
SPEAKER SPOTLIGHT:
Kate Bingham, Managing Partner, SV Health Investors
London, United Kingdom
| |
| |
|
|
|
|
Also Featuring:
- Jorge Aguado, Vice Minister of Science, Argentina
- Kevin Ali, President, MSD International, Merck & Co, Inc.
- Lisa Melton [Moderator], Senior News Editor, Nature Biotechnology
- Kenneth Kaitin, Professor of Medicine and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
| |
| |
|
|
|
|
|
|
BIO 2018 SUPER SESSION SPONSORS:
| |
| |
|
|
|
|
|
|
|
|
|
|
.png)
.png)
沒有留言:
發佈留言